| 000 | 01654 a2200469 4500 | ||
|---|---|---|---|
| 005 | 20250516220035.0 | ||
| 264 | 0 | _c20140930 | |
| 008 | 201409s 0 0 eng d | ||
| 022 | _a1521-7035 | ||
| 024 | 7 |
_a10.1016/j.clim.2014.06.004 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aZhang, Yufei | |
| 245 | 0 | 0 |
_aSystemic injection of TLR1/2 agonist improves adoptive antigen-specific T cell therapy in glioma-bearing mice. _h[electronic resource] |
| 260 |
_bClinical immunology (Orlando, Fla.) _cSep 2014 |
||
| 300 |
_a26-36 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aAntineoplastic Agents _xpharmacology |
| 650 | 0 | 4 |
_aBrain Neoplasms _xtherapy |
| 650 | 0 | 4 |
_aCD8-Positive T-Lymphocytes _xtransplantation |
| 650 | 0 | 4 |
_aCell Proliferation _xdrug effects |
| 650 | 0 | 4 |
_aCell Survival _xdrug effects |
| 650 | 0 | 4 | _aCell- and Tissue-Based Therapy |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aFlow Cytometry |
| 650 | 0 | 4 |
_aGlioma _xtherapy |
| 650 | 0 | 4 | _aImmunotherapy, Adoptive |
| 650 | 0 | 4 |
_aLipoproteins _xpharmacology |
| 650 | 0 | 4 | _aMice |
| 650 | 0 | 4 | _aMice, Inbred C57BL |
| 650 | 0 | 4 | _aPolymerase Chain Reaction |
| 650 | 0 | 4 |
_aToll-Like Receptor 1 _xagonists |
| 650 | 0 | 4 |
_aToll-Like Receptor 2 _xagonists |
| 700 | 1 | _aLuo, Feifei | |
| 700 | 1 | _aLi, Anning | |
| 700 | 1 | _aQian, Jiawen | |
| 700 | 1 | _aYao, Zhenwei | |
| 700 | 1 | _aFeng, Xiaoyuan | |
| 700 | 1 | _aChu, Yiwei | |
| 773 | 0 |
_tClinical immunology (Orlando, Fla.) _gvol. 154 _gno. 1 _gp. 26-36 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/j.clim.2014.06.004 _zAvailable from publisher's website |
| 999 |
_c23917768 _d23917768 |
||